Melinda Buntin, PhD, Mike Curb Professor and Chair of the Department of Health Policy, recently testified before the Senate Health, Education, Labor and Pensions Committee chaired by U.S. Sen. Lamar Alexander.

Vanderbilt University has signed a licensing agreement with Nashville-based start-up Appello Pharmaceuticals, Inc. to advance novel compounds developed by researchers in the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD) for the treatment of Parkinson’s disease.

The Osher Center for Integrative Medicine at Vanderbilt will begin offering a third round of yoga classes for employees suffering from back pain or insomnia.

Patients and medical teams reunited recently in the lobby of Langford Auditorium to celebrate the adult Extracorporeal Membrane Oxygenation (ECMO) Program at Vanderbilt University Medical Center.

A drug used to treat diabetes may point to new therapies for respiratory syncytial virus (RSV) bronchiolitis — inflammation and obstruction of the lungs’ small airways. A multi-disciplinary team of Vanderbilt investigators has demonstrated that liraglutide reduces the inflammatory response to RSV infection in a mouse model of the disease.

In areas of the country disproportionately affected by the opioid crisis, treatment programs are less likely to accept patients paying through insurance of any type or accept pregnant women, a new Vanderbilt study found.

Medical teams at the Vanderbilt Transplant Center (VTC) are leading the way in utilization of hepatitis C-exposed donors for heart transplantation.